Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ZIOPHARM Oncology Inc (NASDAQ:ZIOP)

4.43
Delayed Data
As of Dec 08
 +0.09 / +2.07%
Today’s Change
3.90
Today|||52-Week Range
7.88
-17.20%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$628.9M

Company Description

ZIOPHARM Oncology, Inc. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of a diverse portfolio of cancer therapies. It focuses on developing products in immuno-oncology that employ novel gene expression, control, and cell technologies for the treatment of cancer and graft-versus-host-disease. The company was founded on September 9, 2003 and is headquartered in Boston, MA.

Contact Information

ZIOPHARM Oncology, Inc.
Parris Building
Boston Massachusetts 02129
P:(617) 259-1970
Investor Relations:

Employees

Shareholders

Individual stakeholders25.43%
Other institutional17.61%
Mutual fund holders16.61%

Top Executives

Laurence James Neil CooperChief Executive Officer
David M. MauneyExecutive VP, Chief Operating & Business Officer
Kevin G. LafondPrincipal Financial Officer & Treasurer
Francois LebelChief Medical Officer, EVP-Research & Development
Caesar J. BelbelSecretary, Chief Legal Officer & Executive VP